DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Conatus Pharmaceuticals Q4 EPS $(0.08) Up From $(0.13) YoY, Sales $526K Down From $7.409M YoY

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.08) per share. This is a 38.46 percent increase over losses of $(0.13) per share from the same period last year. The company reported $526 thousand

Benzinga · 03/11/2020 20:48

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.08) per share. This is a 38.46 percent increase over losses of $(0.13) per share from the same period last year. The company reported $526 thousand in sales this quarter. This is a 92.90 percent decrease over sales of $7.409 million the same period last year.